Cargando…
Use of OCT Angiography to Diagnose and Manage Atypical Presentations of Macular Telangiectasia Type 2
Macular telangiectasia Type 2 (MacTel) is a bilateral acquired retinal disease characterized by both vascular changes and atrophy of the retina. The purpose of this case series is to highlight the use of optical coherence tomography angiography (OCTA) as a non-invasive imaging modality to distinguis...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321649/ https://www.ncbi.nlm.nih.gov/pubmed/35887197 http://dx.doi.org/10.3390/ijms23147849 |
_version_ | 1784756099794075648 |
---|---|
author | Moir, John Amin, Shivam V. Khanna, Saira Komati, Rahul Shaw, Lincoln T. Dao, David Hariprasad, Seenu M. Skondra, Dimitra |
author_facet | Moir, John Amin, Shivam V. Khanna, Saira Komati, Rahul Shaw, Lincoln T. Dao, David Hariprasad, Seenu M. Skondra, Dimitra |
author_sort | Moir, John |
collection | PubMed |
description | Macular telangiectasia Type 2 (MacTel) is a bilateral acquired retinal disease characterized by both vascular changes and atrophy of the retina. The purpose of this case series is to highlight the use of optical coherence tomography angiography (OCTA) as a non-invasive imaging modality to distinguish atypical MacTel from other macular conditions with similar presentations. We performed a retrospective review of patients referred to our academic retinal practice with unconfirmed or misdiagnosed MacTel between July 2017 and July 2021. Patients’ OCTA imaging findings were reviewed to guide the appropriate diagnosis and management of atypical MacTel. Fifteen eyes from eight patients were included in this study. Six patients were referred with previous diagnoses of either full-thickness macular hole, lamellar hole, vitreomacular traction (VMT), postoperative cystoid macular edema (CME), or diabetic macular edema (DME). Two patients were referred to us to confirm the diagnosis of MacTel. OCTA revealed telangiectatic vessels in the temporal parafovea of all 15 eyes. OCTA also highlighted previously undiagnosed subretinal neovascularization (SRNV) in seven eyes. OCTA imaging is a valuable imaging modality to distinguish MacTel from other macular conditions, whose treatment courses vary substantially. Due to its ease of use, it holds immense potential in the future as treatments for non-proliferative MacTel emerge. |
format | Online Article Text |
id | pubmed-9321649 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93216492022-07-27 Use of OCT Angiography to Diagnose and Manage Atypical Presentations of Macular Telangiectasia Type 2 Moir, John Amin, Shivam V. Khanna, Saira Komati, Rahul Shaw, Lincoln T. Dao, David Hariprasad, Seenu M. Skondra, Dimitra Int J Mol Sci Article Macular telangiectasia Type 2 (MacTel) is a bilateral acquired retinal disease characterized by both vascular changes and atrophy of the retina. The purpose of this case series is to highlight the use of optical coherence tomography angiography (OCTA) as a non-invasive imaging modality to distinguish atypical MacTel from other macular conditions with similar presentations. We performed a retrospective review of patients referred to our academic retinal practice with unconfirmed or misdiagnosed MacTel between July 2017 and July 2021. Patients’ OCTA imaging findings were reviewed to guide the appropriate diagnosis and management of atypical MacTel. Fifteen eyes from eight patients were included in this study. Six patients were referred with previous diagnoses of either full-thickness macular hole, lamellar hole, vitreomacular traction (VMT), postoperative cystoid macular edema (CME), or diabetic macular edema (DME). Two patients were referred to us to confirm the diagnosis of MacTel. OCTA revealed telangiectatic vessels in the temporal parafovea of all 15 eyes. OCTA also highlighted previously undiagnosed subretinal neovascularization (SRNV) in seven eyes. OCTA imaging is a valuable imaging modality to distinguish MacTel from other macular conditions, whose treatment courses vary substantially. Due to its ease of use, it holds immense potential in the future as treatments for non-proliferative MacTel emerge. MDPI 2022-07-16 /pmc/articles/PMC9321649/ /pubmed/35887197 http://dx.doi.org/10.3390/ijms23147849 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Moir, John Amin, Shivam V. Khanna, Saira Komati, Rahul Shaw, Lincoln T. Dao, David Hariprasad, Seenu M. Skondra, Dimitra Use of OCT Angiography to Diagnose and Manage Atypical Presentations of Macular Telangiectasia Type 2 |
title | Use of OCT Angiography to Diagnose and Manage Atypical Presentations of Macular Telangiectasia Type 2 |
title_full | Use of OCT Angiography to Diagnose and Manage Atypical Presentations of Macular Telangiectasia Type 2 |
title_fullStr | Use of OCT Angiography to Diagnose and Manage Atypical Presentations of Macular Telangiectasia Type 2 |
title_full_unstemmed | Use of OCT Angiography to Diagnose and Manage Atypical Presentations of Macular Telangiectasia Type 2 |
title_short | Use of OCT Angiography to Diagnose and Manage Atypical Presentations of Macular Telangiectasia Type 2 |
title_sort | use of oct angiography to diagnose and manage atypical presentations of macular telangiectasia type 2 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321649/ https://www.ncbi.nlm.nih.gov/pubmed/35887197 http://dx.doi.org/10.3390/ijms23147849 |
work_keys_str_mv | AT moirjohn useofoctangiographytodiagnoseandmanageatypicalpresentationsofmaculartelangiectasiatype2 AT aminshivamv useofoctangiographytodiagnoseandmanageatypicalpresentationsofmaculartelangiectasiatype2 AT khannasaira useofoctangiographytodiagnoseandmanageatypicalpresentationsofmaculartelangiectasiatype2 AT komatirahul useofoctangiographytodiagnoseandmanageatypicalpresentationsofmaculartelangiectasiatype2 AT shawlincolnt useofoctangiographytodiagnoseandmanageatypicalpresentationsofmaculartelangiectasiatype2 AT daodavid useofoctangiographytodiagnoseandmanageatypicalpresentationsofmaculartelangiectasiatype2 AT hariprasadseenum useofoctangiographytodiagnoseandmanageatypicalpresentationsofmaculartelangiectasiatype2 AT skondradimitra useofoctangiographytodiagnoseandmanageatypicalpresentationsofmaculartelangiectasiatype2 |